/
Novo Nordisk A/S
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease.
Mentions
32 mentions · latest on 12 Nov 2026
See which tracked investors hold Novo Nordisk A/S →Ownership and position changes on OwnershipTrace